Rhodopsin

Rhodopsin, also known as visual purple, is a protein encoded by the RHO gene[5] and a G-protein-coupled receptor (GPCR). It is the opsin of the rod cells in the retina and a light-sensitive receptor protein that triggers visual phototransduction in rods. Rhodopsin mediates dim light vision and thus is extremely sensitive to light.[6] When rhodopsin is exposed to light, it immediately photobleaches. In humans, it is regenerated fully in about 30 minutes, after which the rods are more sensitive.[7] Defects in the rhodopsin gene cause eye diseases such as retinitis pigmentosa and congenital stationary night blindness.

This article is about the visual rhodopsin of the vertebrate rods. For other types of rhodopsin, see Retinylidene protein.

RHO
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesRHO, CSNBAD1, OPN2, RP4, rhodopsin, Rhodopsin, visual purple
External IDsOMIM: 180380 MGI: 97914 HomoloGene: 68068 GeneCards: RHO
Orthologs
SpeciesHumanMouse
Entrez

6010

212541

Ensembl

ENSG00000163914

ENSMUSG00000030324

UniProt

P08100

P15409

RefSeq (mRNA)

NM_000539

NM_145383

RefSeq (protein)

NP_000530

NP_663358

Location (UCSC)Chr 3: 129.53 – 129.54 MbChr 6: 115.91 – 115.92 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Names

Rhodopsin was discovered by Franz Christian Boll in 1876.[8][9][10] The name rhodospsin derives from Ancient Greek ῥόδον (rhódon) for "rose", due to its pinkish color, and ὄψις (ópsis) for "sight".[11] It was coined in 1878 by the German physiologist Wilhelm Friedrich Kühne (1837-1900).[12][13]

When George Wald discovered that rhodopsin is a holoprotein, consisting of retinal and an apoprotein, he called it opsin, which today would be described more narrowly as apo-rhodopsin.[14] Today, the term opsin refers more broadly to the class of G-protein-coupled receptors that bind retinal and as a result become a light sensitive photoreceptor, including all closely related proteins.[15][16][17][lower-alpha 1] When Wald and colleges later isolated iodopsin from chicken retinas, thereby discovering the first known cone opsin, they called apo-iodopsin photopsin (for its relation to photopic vision) and apo-rhodopsin scotopsin (for its use in scotopic vision).[18]

General

Rhodopsin is a protein found in the outer segment discs of rod cells. It mediates scotopic vision, which is monochromatic vision in dim light.[7][19] Rhodopsin most strongly absorbs green-blue light (~500 nm)[20][21] and appears therefore reddish-purple, hence the archaic term "visual purple".

Several closely related opsins differ only in a few amino acids and in the wavelengths of light that they absorb most strongly. Humans have, including rhodopsin, nine opsins,[15] as well as cryptochrome (light-sensitive, but not an opsin).[22]

Structure
Cattle rhodopsin

Rhodopsin, like other opsins, is a G-protein-coupled receptor (GPCR).[23][24] GPCRs are chemoreceptors that embed in the lipid bilayer of the cell membranes and have seven transmembrane domains forming a binding pocket for a ligand.[25][26] The ligand for rhodopsin is the vitamin A-based chromophore 11-cis-retinal,[27][28][29][30][31] which lies horizontally to the cell membrane[32] and is covalently bound to a lysine residue (lys296)[33] in the seventh transmembrane domain[34][32] through a Schiff-base.[35][36] However, 11-cis-retinal only blocks the binding pocket and does not activate rhodopsin. It is only activated when 11-cis-retinal absorbs a photon of light and isomerizes to all-trans-retinal,[37][38] the receptor activating form,[39][40] causing conformal changes in rhodopsin (bleaching),[39] which activate a phototransduction cascade.[41] Thus, a chemoreceptor is converted to a light or photo(n)receptor.[16]

The retinal binding lysine is conserved in almost all opsins, only a few opsins having lost it during evolution.[16] Opsins without the lysine are not light sensitive,[42][43][44] including rhodopsin. Rhodopsin is made constitutively (continuously) active by some of those mutations even without light.[45][46][47] Also wild-type rhodopsin is constitutively active, if no 11-cis-retinal is bound, but much less.[48] Therefore 11-cis-retinal is an inverse agonist. Such mutations are one cause of autosomal dominant retinitis pigmentosa.[47] Artificially, the retinal binding lysine can be shifted to other positions, even into other transmembrane domains, without changing the activity.[49]

The rhodopsin of cattle has 348 amino acids, the retinal binding lysine being Lys296. It was the first opsin whose amino acid sequence[50] and 3D-structure were determined.[32] Its structure has been studied in detail by x-ray crystallography on rhodopsin crystals.[51] Several models (e.g., the bicycle-pedal mechanism, hula-twist mechanism) attempt to explain how the retinal group can change its conformation without clashing with the enveloping rhodopsin protein pocket.[52][53][54] Recent data support that rhodopsin is a functional monomer, instead of a dimer, which was the paradigm of G-protein-coupled receptors for many years.[55]

Within its native membrane, rhodopsin is found at a high density facilitating its ability to capture photons. Due to its dense packing within the membrane, there is a higher chance of rhodopsin capturing proteins. However, the high density also provides a disadvantage when it comes to G protein signaling because the diffusion becomes more difficult in a crowded membrane that is packed with the receptor, rhodopsin.[56]

Phototransduction
The visual cycle follows the renewal of the retinal chromophore. It runs in parallel to the phototransduction pathway.

Rhodopsin is an essential G-protein coupled receptor in phototransduction.

Activation

In rhodopsin, the aldehyde group of retinal is covalently linked to the amino group of a lysine residue on the protein in a protonated Schiff base (-NH+=CH-).[33] When rhodopsin absorbs light, its retinal cofactor isomerizes from the 11-cis to the all-trans configuration, and the protein subsequently undergoes a series of relaxations to accommodate the altered shape of the isomerized cofactor. The intermediates formed during this process were first investigated in the laboratory of George Wald, who received the Nobel prize for this research in 1967.[57] The photoisomerization dynamics has been subsequently investigated with time-resolved IR spectroscopy and UV/Vis spectroscopy. A first photoproduct called photorhodopsin forms within 200 femtoseconds after irradiation, followed within picoseconds by a second one called bathorhodopsin with distorted all-trans bonds. This intermediate can be trapped and studied at cryogenic temperatures, and was initially referred to as prelumirhodopsin.[58] In subsequent intermediates lumirhodopsin and metarhodopsin I, the Schiff's base linkage to all-trans retinal remains protonated, and the protein retains its reddish color. The critical change that initiates the neuronal excitation involves the conversion of metarhodopsin I to metarhodopsin II, which is associated with deprotonation of the Schiff's base and change in color from red to yellow.[59]

Phototransduction cascade
Main article: Visual phototransduction

The product of light activation, Metarhodopsin II, initiates the visual phototransduction second messenger pathway by stimulating the G-protein transducin (Gt), resulting in the liberation of its α subunit. This GTP-bound subunit in turn activates a cGMP phosphodiesterase. The cGMP phosphodiesterase hydrolyzes (breaks down) cGMP, lowering its local concentration so it can no longer activate cGMP-dependent cation channels. This leads to the hyperpolarization of photoreceptor cells, changing the rate at which they release transmitters.[60][41]

Deactivation

Meta II (metarhodopsin II) is deactivated rapidly after activating transducin by rhodopsin kinase and arrestin.[61] Rhodopsin pigment must be regenerated for further phototransduction to occur. This means replacing all-trans-retinal with 11-cis-retinal and the decay of Meta II is crucial in this process. During the decay of Meta II, the Schiff base link that normally holds all-trans-retinal and the apoprotein opsin (aporhodopsin) is hydrolyzed and becomes Meta III. In the rod outer segment, Meta III decays into separate all-trans-retinal and opsin.[61] A second product of Meta II decay is an all-trans-retinal opsin complex in which the all-trans-retinal has been translocated to second binding sites. Whether the Meta II decay runs into Meta III or the all-trans-retinal opsin complex seems to depend on the pH of the reaction. Higher pH tends to drive the decay reaction towards Meta III.[61]

Diseases of the retina

Mutations in the rhodopsin gene contribute majorly to various diseases of the retina such as retinitis pigmentosa. In general, the defect rhodopsin aggregates with ubiquitin in inclusion bodies, disrupts the intermediate filament network, and impairs the ability of the cell to degrade non-functioning proteins, which leads to photoreceptor apoptosis.[62] Other mutations on rhodopsin lead to X-linked congenital stationary night blindness, mainly due to constitutive activation, when the mutations occur around the chromophore binding pocket of rhodopsin.[63] Several other pathological states relating to rhodopsin have been discovered including poor post-Golgi trafficking, dysregulative activation, rod outer segment instability and arrestin binding.[63]

See also

Explanatory notes
  1. Hofmann and Lamb[17] use the term opsin in general to mean the group of opsins, however they call apo-rhodopsin in their figure 4 opsin, too.

References
  1. GRCh38: Ensembl release 89: ENSG00000163914 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000030324 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "RHO rhodopsin [Homo sapiens (human)]". NCBI. Retrieved 16 November 2017.
  6. Litmann BJ, Mitchell DC (1996). "Rhodopsin structure and function". In Lee AG (ed.). Rhodopsin and G-Protein Linked Receptors, Part A (Vol 2, 1996) (2 Vol Set). Biomembranes: A Multi-Volume Treatise. Vol. 2. Greenwich, Conn: JAI Press. pp. 1–32. doi:10.1016/S1874-5342(07)80004-3. ISBN 978-1-55938-659-3.
  7. Stuart JA, Brige RR (1996). "Characterization of the primary photochemical events in bacteriorhodopsin and rhodopsin". In Lee AG (ed.). Rhodopsin and G-Protein Linked Receptors, Part A (Vol 2, 1996) (2 Vol Set). Biomembranes: A Multi-Volume Treatise. Vol. 2. Greenwich, Conn: JAI Press. pp. 33–140. doi:10.1016/S1874-5342(07)80005-5. ISBN 978-1-55938-659-3.
  8. Encyclopedia of the Neurological Sciences. Academic Press. 29 April 2014. pp. 441–. ISBN 978-0-12-385158-1.
  9. Giese AC (24 September 2013). Photophysiology: General Principles; Action of Light on Plants. Elsevier. p. 9. ISBN 978-1-4832-6227-7. Retrieved 23 September 2015.
  10. Boll F (1877). "Zur Anatomie und Physiologie der Retina" [On the anatomy and physiology of the retina]. Archiv für Anatomie und Physiologie, Physiologische Abtheilung (in German): 4–35.
  11. "Rhodopsin: History and Etymology for rhodopsin". Merriam-Webster on-line dictionary.
  12. See:
    • Merriam-Webster Online Dictionary: Rhodopsin: History and Etymology for rhodopsin
    • Ewald A, Kühne W (1878). "Untersuchungen über den Sehpurpur" [Investigations into rhodopsin]. Untersuchungen aus dem Physiologischen Institute der Universität Heidelberg (in German). 1: 139–218. From p. 181: "Was den Sehpurpur im Dunkel ändert, pflegt es z. Th. [= zum Theil] in derselben Weise zu thun, wie das Licht, d.h. erst eine gelbe Materie, dann farblose Substanz hervorzubringen. Der Kürze wegen und um dem Auslande unsere Bezeichnungen zugänglich zu machen, kann man sagen, Rhodopsin werde erst in Xanthopsin, dieses in Leukopsin zersetzt." (That which alters visual purple in the dark usually acts to some extent in the same way as light, that is, first producing a yellow material, then a colorless substance. For the sake of brevity, and in order to make our designations more accessible to foreigners, we can say that rhodopsin is first degraded into xanthopsin [- visual yellow], and [then] this is degraded into leucopsin [- visual white].)
  13. Wade NJ (November 2008). "Visual purple (sehpurpur)". Perception. 37 (11): 1617–1620. doi:10.1068/p3711ed. PMID 19189727. S2CID 19145558.
  14. Wald G (December 1951). "The photochemical basis of rod vision". Journal of the Optical Society of America. 41 (12): 949–956. doi:10.1364/josa.41.000949. PMID 14908734.
  15. Terakita A (2005). "The opsins". Genome Biology. 6 (3): 213. doi:10.1186/gb-2005-6-3-213. PMC 1088937. PMID 15774036.
  16. Gühmann M, Porter ML, Bok MJ (August 2022). "The Gluopsins: Opsins without the Retinal Binding Lysine". Cells. 11 (15): 2441. doi:10.3390/cells11152441. PMC 9368030. PMID 35954284. Material was copied and adapted from this source, which is available under a Creative Commons Attribution 4.0 International License.
  17. Hofmann KP, Lamb TD (March 2023). "Rhodopsin, light-sensor of vision". Progress in Retinal and Eye Research. 93: 101116. doi:10.1016/j.preteyeres.2022.101116. PMID 36273969. S2CID 253041556.
  18. Wald G, Brown PK, Smith PH (May 1955). "Iodopsin". The Journal of General Physiology. 38 (5): 623–681. doi:10.1085/jgp.38.5.623. PMC 2147498. PMID 14367777.
  19. Rogers K. "Rhodopsin". Encyclopædia Britannica. Britannica.com. Retrieved 30 January 2016.
  20. Wald G, Brown PK (January 1958). "Human rhodopsin". Science. 127 (3292): 222–226. Bibcode:1958Sci...127..222W. doi:10.1126/science.127.3292.222. PMID 13495499. S2CID 45459123.
  21. Bowmaker JK, Dartnall HJ (January 1980). "Visual pigments of rods and cones in a human retina". The Journal of Physiology. 298 (1): 501–511. doi:10.1113/jphysiol.1980.sp013097. PMC 1279132. PMID 7359434.
  22. Foley LE, Gegear RJ, Reppert SM (June 2011). "Human cryptochrome exhibits light-dependent magnetosensitivity". Nature Communications. 2: 356. Bibcode:2011NatCo...2..356F. doi:10.1038/ncomms1364. PMC 3128388. PMID 21694704.
  23. Casey PJ, Gilman AG (February 1988). "G protein involvement in receptor-effector coupling". The Journal of Biological Chemistry. 263 (6): 2577–2580. doi:10.1016/s0021-9258(18)69103-3. PMID 2830256. S2CID 38970721.
  24. Attwood TK, Findlay JB (February 1994). "Fingerprinting G-protein-coupled receptors". Protein Engineering. 7 (2): 195–203. doi:10.1093/protein/7.2.195. PMID 8170923.
  25. Dixon RA, Kobilka BK, Strader DJ, Benovic JL, Dohlman HG, Frielle T, et al. (May 1986). "Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin". Nature. 321 (6065): 75–79. Bibcode:1986Natur.321...75D. doi:10.1038/321075a0. PMID 3010132. S2CID 4324074.
  26. Dixon RA, Sigal IS, Rands E, Register RB, Candelore MR, Blake AD, Strader CD (March 1987). "Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core". Nature. 326 (6108): 73–77. Bibcode:1987Natur.326...73D. doi:10.1038/326073a0. PMID 2881211. S2CID 4352920.
  27. Wald G (July 1934). "Carotenoids and the Vitamin A Cycle in Vision". Nature. 134 (3376): 65. Bibcode:1934Natur.134...65W. doi:10.1038/134065a0. S2CID 4022911.
  28. Wald G, Brown PK, Hubbard R, Oroshnik W (July 1955). "Hindered Cis Isomers of Vitamin a and Retinene: The Structure of the Neo-B Isomer". Proceedings of the National Academy of Sciences of the United States of America. 41 (7): 438–451. Bibcode:1955PNAS...41..438W. doi:10.1073/pnas.41.7.438. PMC 528115. PMID 16589696.
  29. Brown PK, Wald G (October 1956). "The neo-b isomer of vitamin A and retinene". The Journal of Biological Chemistry. 222 (2): 865–877. doi:10.1016/S0021-9258(20)89944-X. PMID 13367054.
  30. Oroshnik W (June 1956). "The Synthesis and Configuration of Neo-B Vitamin A and Neoretinine b". Journal of the American Chemical Society. 78 (11): 2651–2652. doi:10.1021/ja01592a095.
  31. Oroshnik W, Brown PK, Hubbard R, Wald G (September 1956). "HINDERED CIS ISOMERS OF VITAMIN A AND RETINENE: THE STRUCTURE OF THE NEO-b ISOMER". Proceedings of the National Academy of Sciences of the United States of America. 42 (9): 578–580. Bibcode:1956PNAS...42..578O. doi:10.1073/pnas.42.9.578. PMC 534254. PMID 16589909.
  32. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, et al. (August 2000). "Crystal structure of rhodopsin: A G protein-coupled receptor". Science. 289 (5480): 739–745. Bibcode:2000Sci...289..739P. CiteSeerX 10.1.1.1012.2275. doi:10.1126/science.289.5480.739. PMID 10926528.
  33. Bownds D (December 1967). "Site of attachment of retinal in rhodopsin". Nature. 216 (5121): 1178–1181. Bibcode:1967Natur.216.1178B. doi:10.1038/2161178a0. PMID 4294735. S2CID 1657759.
  34. Hargrave PA, McDowell JH, Curtis DR, Wang JK, Juszczak E, Fong SL, et al. (1983). "The structure of bovine rhodopsin". Biophysics of Structure and Mechanism. 9 (4): 235–244. doi:10.1007/BF00535659. PMID 6342691. S2CID 20407577.
  35. Collins FD (March 1953). "Rhodopsin and indicator yellow". Nature. 171 (4350): 469–471. Bibcode:1953Natur.171..469C. doi:10.1038/171469a0. PMID 13046517. S2CID 4152360.
  36. Pitt GA, Collins FD, Morton RA, Stok P (January 1955). "Studies on rhodopsin. VIII. Retinylidenemethylamine, an indicator yellow analogue". The Biochemical Journal. 59 (1): 122–128. doi:10.1042/bj0590122. PMC 1216098. PMID 14351151.
  37. Hubbard R, Kropf A (February 1958). "The Action of Light on Rhodopsin". Proceedings of the National Academy of Sciences of the United States of America. 44 (2): 130–139. Bibcode:1958PNAS...44..130H. doi:10.1073/pnas.44.2.130. PMC 335377. PMID 16590155.
  38. Kropf A, Hubbard R (November 1959). "The mechanism of bleaching rhodopsin". Annals of the New York Academy of Sciences. 74 (2): 266–280. Bibcode:1959NYASA..74..266K. doi:10.1111/j.1749-6632.1958.tb39550.x. PMID 13627857. S2CID 45830716.
  39. Choe HW, Kim YJ, Park JH, Morizumi T, Pai EF, Krauss N, et al. (March 2011). "Crystal structure of metarhodopsin II". Nature. 471 (7340): 651–655. Bibcode:2011Natur.471..651C. doi:10.1038/nature09789. PMID 21389988. S2CID 4302421.
  40. Wald G (October 1968). "Molecular basis of visual excitation". Science. 162 (3850): 230–239. Bibcode:1968Sci...162..230W. doi:10.1126/science.162.3850.230. PMID 4877437.
  41. Terakita A, Kawano-Yamashita E, Koyanagi M (January 2012). "Evolution and diversity of opsins". Wiley Interdisciplinary Reviews: Membrane Transport and Signaling. 1 (1): 104–111. doi:10.1002/wmts.6.
  42. Katana R, Guan C, Zanini D, Larsen ME, Giraldo D, Geurten BR, et al. (September 2019). "Chromophore-Independent Roles of Opsin Apoproteins in Drosophila Mechanoreceptors". Current Biology. 29 (17): 2961–2969.e4. doi:10.1016/j.cub.2019.07.036. PMID 31447373. S2CID 201420079.
  43. Leung NY, Thakur DP, Gurav AS, Kim SH, Di Pizio A, Niv MY, Montell C (April 2020). "Functions of Opsins in Drosophila Taste". Current Biology. 30 (8): 1367–1379.e6. doi:10.1016/j.cub.2020.01.068. PMC 7252503. PMID 32243853.
  44. Kumbalasiri T, Rollag MD, Isoldi MC, Castrucci AM, Provencio I (March 2007). "Melanopsin triggers the release of internal calcium stores in response to light". Photochemistry and Photobiology. 83 (2): 273–279. doi:10.1562/2006-07-11-RA-964. PMID 16961436. S2CID 23060331.
  45. Robinson PR, Cohen GB, Zhukovsky EA, Oprian DD (October 1992). "Constitutively active mutants of rhodopsin". Neuron. 9 (4): 719–725. doi:10.1016/0896-6273(92)90034-b. PMID 1356370. S2CID 13172583.
  46. Yang T, Snider BB, Oprian DD (December 1997). "Synthesis and characterization of a novel retinylamine analog inhibitor of constitutively active rhodopsin mutants found in patients with autosomal dominant retinitis pigmentosa". Proceedings of the National Academy of Sciences of the United States of America. 94 (25): 13559–13564. Bibcode:1997PNAS...9413559Y. doi:10.1073/pnas.94.25.13559. PMC 28345. PMID 9391065.
  47. Park PS (2014). "Constitutively active rhodopsin and retinal disease". Pharmacology & Therapeutics of Constitutively Active Receptors. Advances in Pharmacology. Vol. 70. pp. 1–36. doi:10.1016/B978-0-12-417197-8.00001-8. ISBN 9780124171978. PMC 4120657. PMID 24931191.
  48. Melia TJ, Cowan CW, Angleson JK, Wensel TG (December 1997). "A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin". Biophysical Journal. 73 (6): 3182–3191. Bibcode:1997BpJ....73.3182M. doi:10.1016/S0006-3495(97)78344-9. PMC 1181221. PMID 9414230.
  49. Devine EL, Oprian DD, Theobald DL (August 2013). "Relocating the active-site lysine in rhodopsin and implications for evolution of retinylidene proteins". Proceedings of the National Academy of Sciences of the United States of America. 110 (33): 13351–13355. Bibcode:2013PNAS..11013351D. doi:10.1073/pnas.1306826110. PMC 3746867. PMID 23904486.
  50. Ovchinnikov YA (November 1982). "Rhodopsin and bacteriorhodopsin: structure-function relationships". FEBS Letters. 148 (2): 179–191. doi:10.1016/0014-5793(82)80805-3. PMID 6759163. S2CID 85819100.
  51. Gulati S, Jastrzebska B, Banerjee S, Placeres ÁL, Miszta P, Gao S, et al. (March 2017). "Photocyclic behavior of rhodopsin induced by an atypical isomerization mechanism". Proceedings of the National Academy of Sciences of the United States of America. 114 (13): E2608–E2615. Bibcode:2017PNAS..114E2608G. doi:10.1073/pnas.1617446114. PMC 5380078. PMID 28289214.
  52. Nakamichi H, Okada T (June 2006). "Crystallographic analysis of primary visual photochemistry". Angewandte Chemie. 45 (26): 4270–4273. doi:10.1002/anie.200600595. PMID 16586416.
  53. Schreiber M, Sugihara M, Okada T, Buss V (June 2006). "Quantum mechanical studies on the crystallographic model of bathorhodopsin". Angewandte Chemie. 45 (26): 4274–4277. doi:10.1002/anie.200600585. PMID 16729349.
  54. Weingart O (September 2007). "The twisted C11=C12 bond of the rhodopsin chromophore--a photochemical hot spot". Journal of the American Chemical Society. 129 (35): 10618–10619. doi:10.1021/ja071793t. PMID 17691730.
  55. Chabre M, le Maire M (July 2005). "Monomeric G-protein-coupled receptor as a functional unit". Biochemistry. 44 (27): 9395–9403. doi:10.1021/bi050720o. PMID 15996094.
  56. Park PS (October 2019). "Rhodopsin Oligomerization and Aggregation". The Journal of Membrane Biology. 252 (4–5): 413–423. doi:10.1007/s00232-019-00078-1. PMC 6790290. PMID 31286171.
  57. The Nobel Foundation. "The Nobel Prize in Physiology or Medicine 1967". Nobelprize.org. Nobel Media AB 2014. Retrieved 12 December 2015.
  58. Yoshizawa T, Wald G (March 1963). "Pre-lumirhodopsin and the bleaching of visual pigments". Nature. 197 (Mar 30): 1279–1286. Bibcode:1963Natur.197.1279Y. doi:10.1038/1971279a0. PMID 14002749. S2CID 4263392.
  59. Matthews RG, Hubbard R, Brown PK, Wald G (November 1963). "Tautomeric Forms of Metarhodopsin". The Journal of General Physiology. 47 (2): 215–240. doi:10.1085/jgp.47.2.215. PMC 2195338. PMID 14080814.
  60. Hofmann KP, Heck M (1996). "Light-induced protein-protein interactions on the rod photoreceptor disc membrane". In Lee AG (ed.). Rhodopsin and G-Protein Linked Receptors, Part A (Vol 2, 1996) (2 Vol Set). Biomembranes: A Multi-Volume Treatise. Vol. 2. Greenwich, Conn: JAI Press. pp. 141–198. doi:10.1016/S1874-5342(07)80006-7. ISBN 978-1-55938-659-3.
  61. Heck M, Schädel SA, Maretzki D, Bartl FJ, Ritter E, Palczewski K, Hofmann KP (January 2003). "Signaling states of rhodopsin. Formation of the storage form, metarhodopsin III, from active metarhodopsin II". The Journal of Biological Chemistry. 278 (5): 3162–3169. doi:10.1074/jbc.M209675200. PMC 1364529. PMID 12427735.
  62. Saliba RS, Munro PM, Luthert PJ, Cheetham ME (July 2002). "The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation". Journal of Cell Science. 115 (Pt 14): 2907–2918. doi:10.1242/jcs.115.14.2907. PMID 12082151.
  63. Mendes HF, van der Spuy J, Chapple JP, Cheetham ME (April 2005). "Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy". Trends in Molecular Medicine. 11 (4): 177–185. doi:10.1016/j.molmed.2005.02.007. PMID 15823756.

Further reading
Wikimedia Commons has media related to Rhodopsins.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.